v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 30, 2021
Apr. 30, 2020
Operating activities    
Net loss $ (82,871) $ (19,222)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 11,955 8,202
Loss on disposal of fixed assets 19 0
Amortization of intangible assets 2,417 103
Amortization of deferred contract acquisition costs 24,376 13,451
Non-cash operating lease cost 2,180 2,283
Provision for bad debts 274 149
Stock-based compensation expense 54,362 23,638
Gain on sale of debt securities, net 0 (1,347)
Accretion of marketable securities purchased at a premium 0 578
Non-cash interest expense 595 151
Change in fair value of strategic investments (4,356) 0
Changes in operating assets and liabilities    
Accounts receivable 31,466 20,651
Deferred contract acquisition costs (36,400) (22,563)
Prepaid expenses and other assets (769) 5,332
Accounts payable (10,562) 4,736
Accrued expenses and other current liabilities 29,229 (1,095)
Accrued payroll and benefits 5,969 648
Operating lease liabilities (2,555) (2,975)
Deferred revenue 109,376 64,805
Other liabilities 12,828 1,052
Net cash provided by operating activities 147,533 98,577
Investing activities    
Purchases of property and equipment (25,796) (9,694)
Capitalized internal-use software and website development (4,434) (1,882)
Purchase of strategic investments (1,309) 0
Business acquisition, net of cash acquired (353,407) 0
Purchases of marketable securities 0 (84,904)
Proceeds from sales of marketable securities 0 639,586
Maturities of marketable securities 0 91,605
Net cash (used in) provided by investing activities (384,946) 634,711
Financing activities    
Proceeds from issuance of common stock upon exercise of stock options 3,754 6,393
Capital contributions from non-controlling interest holders 655 500
Net cash provided by financing activities 2,609 6,893
Effect of foreign exchange rates on cash and cash equivalents 1,193 12
Net (decrease) increase in cash and cash equivalents (233,611) 740,193
Cash and cash equivalents, beginning of period 1,918,608 264,798
Cash and cash equivalents, end of period 1,684,997 1,004,991
Supplemental disclosure of cash flow information:    
Interest paid 11 0
Income taxes paid, net of refunds received 1,385 353
Supplemental disclosure of non-cash investing and financing activities:    
Net increase (decrease) in property and equipment included in accounts payable and accrued expenses 4,294 (723)
Vesting of early exercised stock options 797 873
Equity consideration for acquisitions 4,011 0
Operating lease liabilities arising from obtaining operating right of-use assets 2,591 0
Line of Credit    
Financing activities    
Payment of debt issuance costs (219) 0
Senior Notes    
Financing activities    
Payment of debt issuance costs $ (1,581) $ 0